Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
1.56
↑ 118% above average
Average (5y)
-8.56
Historical baseline
Range
High:7.22
Low:-40.24
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 1.56 | -31.5% |
| 2023 | 2.28 | -68.4% |
| 2022 | 7.22 | +204.3% |
| 2021 | -6.92 | +54.8% |
| 2020 | -15.29 | +62.0% |
| 2019 | -40.24 | - |